Yuan Chi
36 Sanhao Street
Shenyang, 110004, China
Shenyang, 110004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Construction of Outcome Quality Evaluation Indicators for Home Hospice Care in Older Patients with Terminal Cancer in China: A Delphi Study.
Journal: Clinical interventions in aging
Published: January 26, 2026
TRACE Model: Predicting Treatment Response to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma.
Journal: Journal of hepatocellular carcinoma
Published: September 11, 2024
Construction of a Home Hospice Care Program for Older Adults at the End of Life with Chronic Diseases in China: A Delphi Method.
Journal: Clinical interventions in aging
Published: July 09, 2024
Synthetic routes and clinical application of new drugs approved by EMA during 2023.
Journal: European journal of medicinal chemistry
Published: July 06, 2024
Synthetic approaches and clinical application of representative small-molecule inhibitors of phosphodiesterase.
Journal: European journal of medicinal chemistry
Published: May 18, 2024
Synthetic routes and clinical application of Small-Molecule HER2 inhibitors for cancer therapy.
Journal: Bioorganic chemistry
Published: May 18, 2024
Synthetic approaches and application of representative clinically approved fluorine-enriched anti-cancer medications.
Journal: European journal of medicinal chemistry
Published: May 13, 2024
Unlocking the potential of biochar: an iron-phosphorus-based composite modified adsorbent for adsorption of Pb(II) and Cd(II) in aqueous environments and response surface optimization of adsorption conditions.
Journal: Environmental science and pollution research international
Published: January 11, 2024
Influencing factors of home hospice care needs of the older adults with chronic diseases at the end of life in China: a cross-sectional study.
Journal: Frontiers in public health
Published: December 02, 2023
Can G-quadruplex become a promising target in HBV therapy?
Journal: Frontiers in immunology
Published: November 07, 2022
microRNA-206 prevents hepatocellular carcinoma growth and metastasis via down-regulating CREB5 and inhibiting the PI3K/AKT signaling pathway.
Journal: Cell cycle (Georgetown, Tex.)
Published: August 25, 2022
Correction to: Long noncoding RNA lncARSR promotes nonalcoholic fatty liver disease and hepatocellular carcinoma by promoting YAP1 and activating the IRS2/AKT pathway.
Journal: Journal of translational medicine
Published: October 20, 2021
Last Updated: 09/26/2026